Nauka i natura

MedChemExpress

Linerixibat (GSK2330672) is a highly potent, nonabsorbable ASBT(apical sodium-dependent bile acid transporter) inhibitor (hASBT IC50=42 nM) which lowers glucose in an animal model of type 2 diabetes and shows excellent developability properties for evaluating the potential therapeutic utility of a nonabsorbable ASBT inhibitor for treatment of patients with type 2 diabetes.
https://www.medchemexpress.com/GSK2330672.html
Dodał Hubert Rodriguez

Podobne inspiracje

Lubię to Komentuj
MK-4101 is a potent SMO Inhibitor of the Hedgehog Pathw…
life science
Lubię to Komentuj
BAY-876 is a selective GLUT1 inhibitor with an IC50 of…
life science
Lubię to Komentuj
EAI045 is an allosteric inhibitor of mutant EGFR with I…
biochemicals
Lubię to Komentuj
Y-27632 is an ATP-competitive inhibitor of ROCK-I and R…
biochemicals
Lubię to Komentuj
IPI549 is a potent and selective PI3Kγ inhibitor with a…
biochemicals
Lubię to Komentuj
Rigosertib (ON-01910) is a multi-kinase inhibitor and a…
biochemical
Lubię to Komentuj
Telcagepant (MK-0974) is a calcitonin gene-related pept…
biochemical
Lubię to Komentuj
Ripretinib (DCC-2618) is an orally bioavailable, select…
biochemical
Lubię to Komentuj
Acolbifene (EM-652; SCH 57068) is a fourth-generation s…
Lubię to Komentuj
Tapinarof (Benvitimod; WBI 1001; GSK2894512) is a natur…
Lubię to Komentuj
Gepotidacin (GSK2140944) is a novel triazaacenaphthylen…
Lubię to Komentuj
Desidustat is an inhibitor of HIF hydroxylase extracted…
Lubię to Komentuj
Gefapixant is an orally active P2X3 receptor (P2X3R) an…
Lubię to Komentuj
Rimeporide (EMD-87580) is a potent and selective inhibi…
MedChemExpress
Momencik, trwa przetwarzanie danych   loading-animation